Organogenesis Holdings Inc. (ORGO)
Nasdaq: ORGO · Pharmaceutical Preparations · Canton, MA · filing with the SEC since 2015
Grade5.9
◀ Past 5.5● Present 7.0▶ Future 4.8
Filings
323 filings since 2017 beside 316 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026Due nextAccelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.
Filings a yearinsider forms included
7857795540706249
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jun 16, 2026.Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest Nov 13, 2024.SEC letters: 4 in the last 36 months, the newest Dec 20, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 16, 2026
8-K items 5.02, 5.07
Officer or director change; Shareholder vote · Current report
Jun 15, 2026
Sep 25, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Aug 7, 2025
8-K items 1.01, 2.02, 9.01
Major agreement signed; Results released · Current report
Aug 5, 2025
Jun 24, 2025
8-K items 5.02, 5.07
Officer or director change; Shareholder vote · Current report
Jun 23, 2025
40 of 323 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.